Insulet Corporation

PODD 
(NASDAQ) 
 
$ 146,69 <%= Resources.Global.txtUp %>
Opdateret 18:06:39
Ændring % 1,12% Stigning i aktiekurs
Ændring 1,62 Stigning i aktiekurs
Volume 155.245
Høj $ 148,51
Lav $ 142,84
Åben $ 144,97
ISIN
Seneste luk $ 145,07
# af aktier 60,27M
Markedsværdi 8.841,24M USD
I dag

Insulet Corporation
Markedet er åbent (indtil 22:00) - Forsinket 15 min
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  146,69 1,0% Stigning i aktiekurs -2,4% Fald i aktiekurs 23,7% Stigning i aktiekurs 50,5% Stigning i aktiekurs 40,2% Stigning i aktiekurs
Powered by TradingView

Firmaprofil

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. september 2019 18:22:00
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190829.2 - EUROWEB6 - 2019-09-18 18:22:00 - 2019-09-18 18:22:00 - 1 - Website: OKAY